Nocion Therapeutics to Present Preclinical Data Supporting Nocions™ as a Novel Approach for the Treatment of Pain at the Non-Opioid Pain Therapeutics Summit

Nocion Therapeutics, Inc. a biopharmaceutical company developing novel small molecule therapies that selectively silence activated sensory neurons, today announced that preclinical data supporting the ...

Adolore BioTherapeutics Announces FDA Orphan Drug Designation for its Kv7-activating rdHSV-CA8* Therapy in the Treatment of Erythromelalgia

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due ...
Medscape

Mutations Linked to IBS, May Lead to Treatment

Approximately 2% of patients with irritable bowel syndrome (IBS) have a mutation of the SCN5A gene that disrupts sodium channel function, according to a genotype analysis published online March 10 in ...
News Medical

Study reveals how genetic changes in SCN2A gene impact autism and epilepsy

Hyperactive channels were generally associated with seizure onset in the first week of life. More impaired channel function was more common when the age of seizure onset was older. In fact, almost all ...
Medscape

Mechanisms of Disease: Sodium Channels and Neuroprotection in Multiple Sclerosis--Current Status

Nat Clin Pract Neurol. 2008;4(3):159-169. Drug Primary clinical use Protective effect during administration in animal models? Effects of withdrawal in EAE Clinical study Phenytoin Treatment of ...